Congratulations to Jaguar Gene Therapy on presenting preclinical data in an investigational gene therapy at the American Society of Gene and Cell Therapy (ASGCT) this week in Washington, D.C.

Working with pioneers in the life sciences industry is always fulfilling for 35 North. Our important, purposeful work to quickly get a variety of clients’ new products to market with services from site assessments and risk analysis through design, construction, and commissioning has never been more exciting.